Ditto, Dr. Royal. The article in question looks like an infomercial. Here’s another one:
http://www.utsouthwestern.edu/utsw/cda/dept353744/files/513040.html

Here is a recently published study by the same author:
http://journals.lww.com/jaacap/Abstract/2009/02000/Remission_and_Recovery_in_the_Treatment_for.12.aspx

“At week 36, the estimated remission rates for intention-to-treat cases were as follows: combination, 60%; fluoxetine, 55%; cognitive-behavioral therapy, 64%; and overall, 60%.”

According to ClinicalTrials.gov, up to 432 subjects were to be enrolled. Where did the extra 7 subjects come from? As well, the data could be 4 – 10 years old:
http://www.clinicaltrials.gov/ct2/show/NCT00006286?term=emslie+tads&rank=1

Compare these results with a prior study:
http://www.nimh.nih.gov/science-news/2007/depressed-adolescents-respond-best-to-combination-treatment.shtml

NIMH has not posted a news release about this study on its Web site.

And yet another recent publication by the same author—the “no harm done” study:
http://ajp.psychiatryonline.org/cgi/content/abstract/appi.ajp.2008.08040487v1

“At week 36, the response rate was 82% in the placebo/open group and 83% in the active treatment groups. The remission rate was 48% in the placebo/open group and 59% in the active treatment groups, a difference that approached statistical significance.

Remission rates at 9 months were lower in patients treated initially with placebo, but 3 months of placebo treatment was not associated with any harm or diminished response to subsequent treatment.”

Key words: “approached” statistical significance

Again, according to ClinicalTrials.gov, up to 432 subjects were to be enrolled. Where did the extra 7 subjects come from? And the data could be 4 – 10 years old:
http://www.clinicaltrials.gov/ct2/show/NCT00006286?term=emslie+tads&rank=1

Here are two news releases on the study:
http://www.utsouthwestern.edu/utsw/cda/dept353744/files/513040.html

http://www.nimh.nih.gov/science-news/2009/adolescents-with-depression-not-harmed-in-studies-using-placebo.shtml

The protocol and sample consent forms for the Treatment for Adolescents With Depression Study (TADS) may be found on the study Web site:
https://trialweb.dcri.duke.edu/tads/templates.html

NIMH NEWS RELEASES ON THE TREATMENT FOR ADOLESCENTS WITH DEPRESSION STUDY (TADS)
August 17, 2004 Combination Treatment Most Effective in Adolescents with Depression
October 1, 2007 Depressed Adolescents Respond Best to Combination Treatment
April 8, 2008 Maintenance Treatment Crucial for Teens’ Recovery from Depression
May 12, 2008 Medication-only Therapy and Combination Therapy Both Cost Effective for Treating Teens with Depression
January 15, 2009 Adolescents with Depression Not Harmed in Studies Using Placebo

FEBRUARY 2009 TADS PUBLICATION
“Most depressed adolescents in all three treatment modalities achieved remission at the end of 9 months of treatment.” Remission and Recovery in the Treatment for Adolescents With Depression Study (TADS): Acute and Long-Term Outcomes [J Am Acad Child Adolesc Psychiatry 2009]

A MUST-SEE VIDEO
September 15, 2006 Treatment for Adolescents With Depression Study (TADS)
Link: rtsp://real.nih.gov/advisory/namh091506.rm?start=01:53:16.0&end=02:15:17.0

insurance companies do not pay psychiatrists at the rate they want to do psychotherapy

this makes talk therapy the domain of psychologists and counselors who do not have the clout of
medical doctors

the reimbursement structures mental health treatment and determines research as well as who gets medicine or talk therapy

there is no value for psychiatry in talk therapy except when done in conjuction with medication